Congenital muscular dystrophy
To participate in this study, contact: Nigel Clarke
Research site: The Children’s Hospital at Westmead, Institute for Neuroscience and Muscle Research (INMR)
Disorder/Disease | Congenital muscular dystrophy (CMD) |
Coordinator | Nigel Clarke |
Project aim/s | Identifying new genetic causes of CMD and genotype/phenotype correlations in CMD |
Methods | 1. Diagnose patients with known genetic causes using protein studies, genetic studies and collaborations (e.g. Shireen Lamande in Melbourne for COLVI studies) |
Approach likely to incorporate Perth NMD-gene screen | |
2. New gene discovery using exome sequencing pipeline | |
3. Analyse clinical phenotypes to improve patient diagnosis and treatment | |
Patient inclusion/exclusion criteria | All patients diagnosed with congenital muscular dystrophy in Australia and New Zealand |
Patient information required for the study | Clinical information, pathology report, +/- muscle MRI |
Supporting documentation that can be provided | INMR Biospecimen Bank information sheets & consent form, INMR exome sequencing information sheet & consent form. |
Closing date for patient registration | Indefinite |
Contact | Nigel Clarke |